Search

everythinglearnresearchcommunity

for

Search:↓

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

The conclusion is that using light-sheet fluorescence microscopy with a special solution can effectively create detailed 3D images of human skin for dermatological research.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Some drugs for inflammation may cause psoriasis-like hair loss.

Finasteride can cause rare but serious skin rashes.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Fisetin may help treat psoriasis and reduce skin inflammation.

Metformin is effective for various skin disorders but may cause skin side effects.

Some children with methylmalonic and propionic acidaemias have skin problems related to their condition and diet.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Hidradenitis suppurativa is likely caused by blocked hair follicles, not apocrine glands.

A man developed an allergic skin reaction from a therapy cap used for hair loss treatment.

Experts don't fully agree on how to diagnose certain hair growth disorders and more research is needed to understand them better.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

ZNF750 helps keep hair follicles healthy and prevents skin inflammation.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Hedgehog signaling is crucial for hair development, cadherins affect cell adhesion, neutrophils play a role in skin lesions, and BP230 autoantibodies impact skin stability.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Switching from infliximab to Ustekinumab improved both hair loss and Crohn's symptoms in the patient.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.